Analysis of fexofenadine in pharmaceutical formulations using tris(1,10-phenanthroline)-ruthenium(II) peroxydisulphate chemiluminescence system in a multichip device

Haider A J Al Lawati*, Zeiyana M. Al Dahmani, Fakhr Eldin O Suliman, Salma M Z Al Kindy, Ali M. Al-Lawati

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

A simple, rapid and sensitive method has been developed for the analysis of fexofenadine (FEX) in pharmaceutical formulations, using a tris(1,10- phenanthroline)-ruthenium(II) [Ru(phen) 3 2+] peroxydisulphate chemiluminescence (CL) system in a multichip device. Various parameters that influence the CL signal intensity were optimized. These included pH, flow rates and concentration of reagents used. Under optimum conditions, a linear calibration curve in the range 0.05-5.0 μg/mL was obtained. The detection limit was found to be 0.001 μg/mL. The procedure was applied to the analysis of FEX in pharmaceutical products and was found to be free from interference from concomitants usually present in these preparations.

Original languageEnglish
Pages (from-to)762-767
Number of pages6
JournalLuminescence
Volume26
Issue number6
DOIs
Publication statusPublished - Nov 2011

Keywords

  • ammonium peroxodisulphate
  • chemiluminescence
  • fexofenadine
  • microfluidics
  • multichip
  • tris(1,10- phenanthroline)-ruthenium(II)

ASJC Scopus subject areas

  • Biophysics
  • Chemistry (miscellaneous)

Fingerprint

Dive into the research topics of 'Analysis of fexofenadine in pharmaceutical formulations using tris(1,10-phenanthroline)-ruthenium(II) peroxydisulphate chemiluminescence system in a multichip device'. Together they form a unique fingerprint.

Cite this